DR. MICHAEL ROSSBACH 

 

Prof. Dr. Rossbach is a seasoned life and health sciences professional, with expertise in immunology, diagnostics, cell-based therapeutics, neuroscience, and genomics.  Since August 2019, Dr. Rossbach is the Head of Technology Scouting at the Eppendorf Group. Prior to that, from 2016 on, he was the VP Global Pharma Partnering of Vela Diagnostics (Singapore/Germany/USA) and worked on clinical and molecular diagnostics (NGS and qPCR-based) to advance precision medicine. Prior to joining Vela Diagnostics, Dr. Rossbach served as the Director for Strategic Alliances at the Genome Institute of Singapore (GIS) for many years. Prior to his GIS appointment, he was a group leader at the Institute of Reconstructive Neurobiology, University of Bonn (Germany), and the Business Development Manager of LIFE&BRAIN, a translational incubator in neuroscience. 

 

Dr. Rossbach holds academic appointments at the National University of Singapore (NUS), at the German Institute of Science and Technology (TUM Asia) in Singapore, at INSEAD Management School (Entrepreneur-in-Residence) and he is Prof. and a member of the Faculty of the Witten School of Management (Witten Group, Germany).  Dr. Rossbach studied biochemistry (Ph.D. in immunology) at the University of Bonn (Germany), the University of New South Wales (Sydney, Australia), at the University of Witten/Herdecke (Witten, Germany), at the Max-Planck Institute for Molecular Physiology (Dortmund, Germany) and at Harvard Medical School (Boston, USA).  

© 2009 by Beacon Capital